Barclays Maintains Underweight on Virtus Inv, Lowers Price Target to $125

Benzinga Newsdesk www.benzinga.com Negative 86.0%

Neg 86% Neu 0% Pos 0%

Barclays analyst Benjamin Budish maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $128 to $125.